By Josh Beckerman

Shares of Soliton Inc. recently traded up 12% to $22.54 as a Nasdaq alert indicated that the closing of the company's sale to AbbVie Inc. is imminent.

Soliton's technology is used for tattoo removal and temporarily improving the appearance of cellulite.

Nasdaq said the $22.60-a-share deal is tentatively scheduled to close prior to the market open on Thursday. In anticipation of the closing, the stock will be halted immediately following the after-hours session at 8 p.m. EST on Wednesday.

Write to Josh Beckerman at josh.beckerman@wsj.com

(END) Dow Jones Newswires

12-14-21 1410ET